Pathstone Family Office’s BlackRock Health Sciences Trust BME Stock Holding History

Pathstone Family Office’s Portfolio BME Stock Details BME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,443	Closed	-$252K	–	1224
2022 Q4	$252K	Buy	+2,443	New	+$104K	﹤0.01%	994
2021 Q1	–	Sell	-2,165	Closed	-$103K	–	744
2020 Q4	$103K	Buy	+2,165	New	+$98.2K	﹤0.01%	381

Other funds holding BME

NRW

Nova R Wealth Overland Park, Kansas $343M AUM 17.7% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Cornerstone Advisory Hunt Valley, Maryland $1.21B AUM 19.13% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Pathstone Family Office's BME Position: Q1 2023 in Review

Pathstone Family Office sold out of BlackRock Health Sciences Trust (BME) in Q1 2023, closing a stake of 2,443 shares — an estimated $252K sold.

Pathstone Family Office first reported a position in BME in Q4 2020 and held it in 2 quarters. The position peaked at $252K in Q4 2022. 71 funds tracked by Wall St. Rank hold BME as of Q1 2023.

Pathstone Family Office reported no remaining BlackRock Health Sciences Trust position as of Q1 2023 after selling out during the quarter.
Pathstone Family Office sold 2,443 BlackRock Health Sciences Trust shares in Q1 2023, an estimated $252K.
Pathstone Family Office first reported a position in BlackRock Health Sciences Trust in Q4 2020 and held it in 2 quarters.
Pathstone Family Office's BlackRock Health Sciences Trust position peaked at $252K in Q4 2022.
71 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q1 2023.

Based on Pathstone Family Office's 13F filing for Q1 2023, filed 15 May 2023.